EPA-Approved SARS-CoV-2 Disinfectants
7 rows where "Date_on_List_N" is on date 2021-04-27 and Formulation_type contains "Dilutable" sorted by Formulation_type
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient
ID
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type ▼
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
1105 |
6836-346 |
Increased Risk |
Quaternary ammonium |
Lonzagard RCS-256 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-04-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1106 |
6836-347 |
Increased Risk |
Quaternary ammonium |
Lonzagard RCS-128 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-04-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1107 |
6836-348 |
Increased Risk |
Quaternary ammonium |
Lonzagard RCS-128 PLUS |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-04-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1108 |
6836-349 |
Increased Risk |
Quaternary ammonium |
Lonzagard RCS-256 Plus |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-04-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1442 |
6836-366 |
Increased Risk |
Quaternary ammonium |
Nugen MB5N-64 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-04-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1484 |
6836-364 |
Increased Risk |
Quaternary ammonium |
Nugen MB5N-256 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-04-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1485 |
6836-365 |
Increased Risk |
Quaternary ammonium |
Nugen MB5N-128 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
1.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-04-27 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |